<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02907398</url>
  </required_header>
  <id_info>
    <org_study_id>ADHERE UAS Registry</org_study_id>
    <nct_id>NCT02907398</nct_id>
  </id_info>
  <brief_title>Adherence and Outcome of Upper Airway Stimulation (UAS) for OSA International Registry</brief_title>
  <official_title>Adherence and Outcome of Upper Airway Stimulation (UAS) for OSA International Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Inspire Medical Systems, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Inspire Medical Systems, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Inspire intends to conduct this registry to: 1) collect Inspire therapy clinical evidence in
      the clinical practice setting; 2) collect additional information on the effectiveness, use
      and safety in the commercial setting; and 3) engage physician customers to report the
      collective outcome within a group of properly trained programs that utilize Inspire therapy
      on a regular basis.

      In addition, a sub-study will be conducted under this Registry at a limited number of
      Registry centers and will include a cohort of Registry patients and a cohort of patients who
      have not received the Inspire therapy device due to denial of insurance coverage. The two
      sub-study cohorts' quality of life and AHI data will be compared.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This registry is a multi-center, prospective, observational registry, conducted in the United
      States and Europe. Some data may be collected retrospectively in patients currently implanted
      (implanted prior to enrollment) through the 12-month follow-up time frame. The CE-marked and
      FDA-approved Inspire system will be used within its intended use, allowing for of use of any
      future approved system component models. This protocol does not include any additional
      stressful or invasive tests, which are not a part of standard of care.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 19, 2016</start_date>
  <completion_date type="Anticipated">September 2019</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Change in Apnea Hypopnea (AHI) from Baseline to 12-Months</measure>
    <time_frame>Baseline through 12 months</time_frame>
    <description>Apnea Hypopnea Index (AHI) is a measure of OSA severity. The AHI will be determined by the AHI score at the post-titration visit compared with the pre-implant baseline score.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Epworth Sleepiness Scale (ESS) from Baseline to 12 Months</measure>
    <time_frame>Baseline through 12 months</time_frame>
    <description>The Epworth Sleepiness Scale (ESS) is a validated instruction that rates a subject's daytime sleepiness. The ESS efficacy endpoint will be determined by the ESS score at the 12-month follow-up as compared to baseline.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient Experience with Therapy (PET)</measure>
    <time_frame>Through 12 months</time_frame>
    <description>The PET is a survey deigned to collect information about patients' experience with the Inspire therapy. Information will be collected once the therapy is activated about relative satisfaction with the therapy over time.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Therapy Adherence</measure>
    <time_frame>Through 12 months</time_frame>
    <description>Therapy use, reported as hours of use per week, is record by Inspire device and can be collected upon interrogation of the device in the clinic. This value can be used to quantify device use and adherence over time.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Advance or Additional Titrations</measure>
    <time_frame>Through 12 months</time_frame>
    <description>The patient will report the number of in-office or sleep lab device titrations completed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical Assessment</measure>
    <time_frame>Baseline through 12 months</time_frame>
    <description>Blood pressure, and height (in either cm or in) &amp; weight (in either kg or lbs) will be used to calculate Body Mass Index at baseline and through study completion.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Global Impression (CGI-I)</measure>
    <time_frame>Baseline through 12 months</time_frame>
    <description>The CGI-I is a seven point scale that requires the clinician to assess how much the patient's illness has improved or worsened relative to a baseline state at the beginning of the intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Device Data Collection</measure>
    <time_frame>Through 12 months</time_frame>
    <description>Device programming and adjustment data recorded during follow-up visits will be collected from physician and patient programmers.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">2500</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>ADHERE</arm_group_label>
    <description>This group will include 250 patients who have been implanted with the Inspire therapy system, enrolled in the ADHERE Registry, and are willing to complete a follow-up home sleep apnea test (HSAT).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CONTROL</arm_group_label>
    <description>This group will include 100 patients who have been denied insurance coverage of the Inspire therapy system implant by their provider, have had no intervention (Inspire), and are willing to complete a HSAT and provide information about their OSA treatment after denial.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Inspire therapy</intervention_name>
    <arm_group_label>ADHERE</arm_group_label>
    <other_name>ADHERE</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <arm_group_label>CONTROL</arm_group_label>
    <other_name>CONTROL</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients scheduled for an Inspire implant or who had an Inspire implant prior to the
        initiation of the Registry. In addition, those patients who were denied insurance coverage
        for the implant.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Any patient implanted with or receiving an Inspire implant, who meets the following
        criteria, is eligible to participate in the registry:

          1. Must be a legal adult

          2. Capable of giving informed consent, as required per institution

          3. Willing to return for routine clinic visits as required for Inspire therapy management

        Exclusion Criteria:

        Any patient who meets any of the following criteria will not be eligible to participate in
        the registry

          1. Has a life expectancy of less than 1 year

          2. Any reason the clinician deems patient is unfit for participation in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Quan Ni, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Inspire Medical Systems, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amy Geis</last_name>
    <phone>763-957-5035</phone>
    <email>amygeis@inspiresleep.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>The University of Alabama for the University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294-0111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Kirk Withrow, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Southern California</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Eric Kezirian, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MedStar Washington Hospital Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Stanley H. Chia, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Florida Health</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margaret Hamer</last_name>
      <phone>352-294-5685</phone>
      <email>mjn18@ufl.edu</email>
    </contact>
    <investigator>
      <last_name>John Harwick, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kansas University Medical Center</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bryan Humphrey</last_name>
      <phone>913-588-3759</phone>
      <email>bhumphrey@kumc.edu</email>
    </contact>
    <investigator>
      <last_name>Christopher Larsen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cheryl Stibbe</last_name>
      <phone>612-625-1435</phone>
      <email>edinx004@umn.edu</email>
    </contact>
    <investigator>
      <last_name>Conrad Iber, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cornell University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospitals Cleveland Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Andrews</last_name>
      <phone>216-844-2386</phone>
      <email>Mary.Andrews@UHhospitals.org</email>
    </contact>
    <contact_backup>
      <last_name>Stacy Pot</last_name>
      <email>Stacy.Pot@UHhospitals.org</email>
    </contact_backup>
    <investigator>
      <last_name>Kingman Strohl, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mark Weidenbecher, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104-6061</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nadia Azad</last_name>
      <email>Nadia.Azad@uphs.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>Richard Schwab, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University and Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beth Duddy</last_name>
      <phone>215-503-6828</phone>
      <email>elizabeth.duddy@jefferson.edu</email>
    </contact>
    <investigator>
      <last_name>Maurits Boon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tina Harrison</last_name>
      <phone>412-232-7207</phone>
      <email>harrisonta@upmc.edu</email>
    </contact>
    <investigator>
      <last_name>Ryan Soose, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Lubeck</name>
      <address>
        <city>Lubeck</city>
        <zip>23562</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Armin Steffen, PD Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universit√§ts-HNO-Klinik Mannheim</name>
      <address>
        <city>Mannheim</city>
        <zip>68167</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oliver Schmidt</last_name>
      <email>Oliver.Schmidt@umm.de</email>
    </contact>
    <investigator>
      <last_name>Joachim Maurer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum rechts der Isar der Technischen Universitat Munchen</name>
      <address>
        <city>Munich</city>
        <zip>81675</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Clemens Heiser, PD Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 30, 2016</study_first_submitted>
  <study_first_submitted_qc>September 15, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2016</study_first_posted>
  <last_update_submitted>February 28, 2018</last_update_submitted>
  <last_update_submitted_qc>February 28, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Neurostimulation</keyword>
  <keyword>Hypoglossal nerve</keyword>
  <keyword>Tongue</keyword>
  <keyword>Upper airway stimulation</keyword>
  <keyword>Surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

